Appreciate the logic. There is big money floating around. If SI covers his bases and goes for data that can not be interpreted by the FDA as incomplete e.g. adult RCT trial / maybe even a targeted controlled study in children then surely money will flow in. Financiers may hold back if they feel like there could be a gap in BLA#3 data. They won't in my opinion if all bases are covered. The Blaster need to get this right, no holes, very little interpretation. Straight bat. Ignore the ethical dilemma, i.e. 'the trolley problem'.
'So, would you pull the lever, leading to one death but saving five? This is the crux of the classic thought experiment known as the trolley dilemma, developed by philosopher Philippa Foot in 1967'.
CEO Itescu needs to go, page-72
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
91.5¢ |
Change
-0.010(1.08%) |
Mkt cap ! $1.044B | |||
| Open | High | Low | Value | Volume |
| 94.0¢ | 94.0¢ | 91.5¢ | $1.609M | 1.737M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 12 | 131951 | 91.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 92.5¢ | 22000 | 1 |
View Market Depth
| Last trade - 16.10pm 10/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |